Table 1 The 23 EBV peptides used for... | American Society of Hematology

Table 1

The 23 EBV peptides used for T-cell stimulation and isolation

Type	Short name	Amino acid sequence	Antigen	HLA restriction
Class I	CLG	CLGGLLTMV¹⁵	LMP2	A*0201
	GLC	GLCTLVAML^16,17	BMLF1	A*0201
	YVL	YVLDHLIVV¹⁸	BRLF1	A*0201
	RLR	RLRAEAQVK¹⁹	EBNA3A	A*0301
	RPP	RPPIFIRRL²⁰	EBNA3A	B*0702
	QPR	QPRAPIRPI²⁰	EBNA3C	B*0702
	QAK	QAKWRLQTL²¹	EBNA3A	B*0801
	RAK	RAKFKQLL²²	BZLF1	B*0801
	IVT	IVTDFSVIK²³	EBNA3B	A*1101
	DEV	DEVEFLGHY¹⁷	BMLF1	B*1801
	RYS	RYSIFFDYM²¹	EBNA3A	A*2402
	TYS	TYSAGIVQI²⁴	EBNA3B	A*2402
	TYP	TYPVLEEMF²⁵	BRLF1	A*2402
	RRIY	RRIYDLIEL²⁶	EBNA3C	B*2702/04/05
	YPL	YPLHEQHGM²⁷	EBNA3A	B*3501
	EPL	EPLPQGQLTAY¹⁸	BZLF1	B*3501
	IED	IEDPPFNSL²⁷	LMP2	B*4001
	KEH	KEHVIQNAF²⁸	EBNA3C	B*4402
	VEI	VEITPYKPTW²⁴	EBNA3B	B*44
Class II	PYYV	PYYVVDLSVRGM²⁹	BHRF1	DRB1*04
	FGQL	FGQLTPHTKAVYQPR³⁰	BLLF1	DRB1*13
	IPQC	IPQCRLTPLSRLPFG^31,32	EBNA1	DRB1*13/14
	TDAW	TDAWRFAMNYPRNPT³³	BNRF1	DRB1*15

Type	Short name	Amino acid sequence	Antigen	HLA restriction
Class I	CLG	CLGGLLTMV¹⁵	LMP2	A*0201
	GLC	GLCTLVAML^16,17	BMLF1	A*0201
	YVL	YVLDHLIVV¹⁸	BRLF1	A*0201
	RLR	RLRAEAQVK¹⁹	EBNA3A	A*0301
	RPP	RPPIFIRRL²⁰	EBNA3A	B*0702
	QPR	QPRAPIRPI²⁰	EBNA3C	B*0702
	QAK	QAKWRLQTL²¹	EBNA3A	B*0801
	RAK	RAKFKQLL²²	BZLF1	B*0801
	IVT	IVTDFSVIK²³	EBNA3B	A*1101
	DEV	DEVEFLGHY¹⁷	BMLF1	B*1801
	RYS	RYSIFFDYM²¹	EBNA3A	A*2402
	TYS	TYSAGIVQI²⁴	EBNA3B	A*2402
	TYP	TYPVLEEMF²⁵	BRLF1	A*2402
	RRIY	RRIYDLIEL²⁶	EBNA3C	B*2702/04/05
	YPL	YPLHEQHGM²⁷	EBNA3A	B*3501
	EPL	EPLPQGQLTAY¹⁸	BZLF1	B*3501
	IED	IEDPPFNSL²⁷	LMP2	B*4001
	KEH	KEHVIQNAF²⁸	EBNA3C	B*4402
	VEI	VEITPYKPTW²⁴	EBNA3B	B*44
Class II	PYYV	PYYVVDLSVRGM²⁹	BHRF1	DRB1*04
	FGQL	FGQLTPHTKAVYQPR³⁰	BLLF1	DRB1*13
	IPQC	IPQCRLTPLSRLPFG^31,32	EBNA1	DRB1*13/14
	TDAW	TDAWRFAMNYPRNPT³³	BNRF1	DRB1*15

For a comprehensive review of EBV-derived T-cell epitopes, see Hislop et al.¹